Image pharmaphorum Editor Digital Accelerating patient engagement in the digital health era Understanding the person behind the patient is a crucial part of medicine, one that healthcare providers can use to improve the efficacy of treatments. Digital Powered by digital: driving transformation and innovation in... Digital health is transforming the way that we approach healthcare, but how can companies make the most of this new multi-channel engagement model? Digital Pushing the right buttons for transformative digital health Digital health and technologies offer a wealth of opportunities, but digital needs to become part of a company’s DNA to achieve transformation. Oncology AI providing the edge against cancer? The global R&D pipeline is dominated by potential treatments in oncology and this is also where the investment is flowing. Load more results
Digital Accelerating patient engagement in the digital health era Understanding the person behind the patient is a crucial part of medicine, one that healthcare providers can use to improve the efficacy of treatments.
Digital Powered by digital: driving transformation and innovation in... Digital health is transforming the way that we approach healthcare, but how can companies make the most of this new multi-channel engagement model?
Digital Pushing the right buttons for transformative digital health Digital health and technologies offer a wealth of opportunities, but digital needs to become part of a company’s DNA to achieve transformation.
Oncology AI providing the edge against cancer? The global R&D pipeline is dominated by potential treatments in oncology and this is also where the investment is flowing.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
